A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.

[1]  I. Lukashevich,et al.  Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses , 2007, Virus Genes.

[2]  Barbara S. Stewart,et al.  Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2 , 2006, Journal of Virology.

[3]  Igor S. Lukashevich and Maria S. Salvato Lassa Virus Genome , 2006 .

[4]  R. Charrel,et al.  Phylogeny and evolution of old world arenaviruses. , 2006, Virology.

[5]  M. Wolfe,et al.  Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.

[6]  L. Fernando,et al.  Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment , 2006, The Lancet.

[7]  M. Puig,et al.  CpG Oligodeoxynucleotides Protect Newborn Mice from a Lethal Challenge with the Neurotropic Tacaribe Arenavirus , 2006, The Journal of Immunology.

[8]  M. Georges-Courbot,et al.  Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. , 2006, Microbes and infection.

[9]  V. Deubel,et al.  A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. , 2006, Virology.

[10]  D. Hassett,et al.  Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology. , 2006, The Journal of clinical investigation.

[11]  P. Darlu,et al.  Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. , 2006, The Journal of general virology.

[12]  I. Lukashevich,et al.  A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses , 2005, Journal of Virology.

[13]  K. Sundar,et al.  Lassa Fever Virus Peptides Predicted by Computational Analysis Induce Epitope-Specific Cytotoxic-T-Lymphocyte Responses in HLA-A2.1 Transgenic Mice , 2005, Clinical Diagnostic Laboratory Immunology.

[14]  M. Buchmeier,et al.  Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein. , 2005, Virology.

[15]  S. Spector,et al.  Yellow fever vaccine , 1972, Archiv für die gesamte Virusforschung.

[16]  Update on Lassa fever in West Africa. , 2005, Releve epidemiologique hebdomadaire.

[17]  I. Lukashevich,et al.  Ribonucleic acids of Machupo and Lassa viruses , 2005, Archives of Virology.

[18]  I. Lukashevich,et al.  Some biochemical properties of Lassa virus RNA and polypeptides , 1986, Medical Microbiology and Immunology.

[19]  M. Georges-Courbot,et al.  Human Macrophages, but Not Dendritic Cells, Are Activated and Produce Alpha/Beta Interferons in Response to Mopeia Virus Infection , 2004, Journal of Virology.

[20]  R. Hewson,et al.  Evidence of segment reassortment in Crimean-Congo haemorrhagic fever virus. , 2004, The Journal of general virology.

[21]  Lassa fever: epidemiology, clinical features, and social consequences , 2004, BMJ : British Medical Journal.

[22]  I. Lukashevich,et al.  LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration , 2004, Archives of Virology.

[23]  A. Barrett,et al.  Ngari Virus Is a Bunyamwera Virus Reassortant That Can Be Associated with Large Outbreaks of Hemorrhagic Fever in Africa , 2004, Journal of Virology.

[24]  J. McCormick,et al.  Lassa fever vaccine , 2004, Expert review of vaccines.

[25]  A. Hoerauf,et al.  Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. , 2004, Virology.

[26]  S. Günther,et al.  Inhibition of Different Lassa Virus Strains by Alpha and Gamma Interferons and Comparison with a Less Pathogenic Arenavirus , 2004, Journal of Virology.

[27]  M. Georges-Courbot,et al.  Lassa Virus Infection of Human Dendritic Cells and Macrophages Is Productive but Fails to Activate Cells1 , 2004, The Journal of Immunology.

[28]  Heinz Feldmann,et al.  New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. , 2003, Virology.

[29]  R. Ahmed,et al.  Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. , 2003, Virology.

[30]  Persephone Borrow,et al.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.

[31]  R. Rico-Hesse,et al.  High genetic divergence and recombination in Arenaviruses from the Americas. , 2002, Virology.

[32]  Philip K. Russell,et al.  Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.

[33]  J. Clegg,et al.  Molecular phylogeny of the arenaviruses. , 2002, Current topics in microbiology and immunology.

[34]  P. Jahrling,et al.  Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses , 2001, Journal of Virology.

[35]  L. Zhang,et al.  Reassortant analysis of guinea pig virulence of pichinde virus variants. , 2001, Virology.

[36]  N. Seidah,et al.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. McCormick,et al.  Towards a human Lassa fever vaccine , 2001, Reviews in medical virology.

[38]  G. Neumann,et al.  Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer , 2001, Journal of Virology.

[39]  M. Bray The role of the Type I interferon response in the resistance of mice to filovirus infection. , 2001, The Journal of general virology.

[40]  I. Lukashevich,et al.  Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. , 2001, Journal of human virology.

[41]  S. Günther,et al.  Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. , 2000, Emerging infectious diseases.

[42]  Stuart T. Nichol,et al.  Genetic Diversity among Lassa Virus Strains , 2000, Journal of Virology.

[43]  L. Hutwagner,et al.  Effective Vaccine for Lassa Fever , 2000, Journal of Virology.

[44]  R. Welsh,et al.  Bystander Sensitization to Activation-Induced Cell Death as a Mechanism of Virus-Induced Immune Suppression , 2000, Journal of Virology.

[45]  A. Hoerauf,et al.  Characterization of Human CD4+ T-Cell Clones Recognizing Conserved and Variable Epitopes of the Lassa Virus Nucleoprotein , 2000, Journal of Virology.

[46]  L. Xia,et al.  Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein. , 2000, Vaccine.

[47]  I. Lukashevich,et al.  Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL‐8 and TNF‐α gene expression , 1999, Journal of medical virology.

[48]  P. Zanotto,et al.  Genetic Reassortment of Rift Valley Fever Virus in Nature , 1999, Journal of Virology.

[49]  C. Peters,et al.  Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. , 1997, Molecular phylogenetics and evolution.

[50]  I. Lukashevich,et al.  Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. , 1997, Virology.

[51]  M. Sabattini,et al.  Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis. Its potential use for detection of uncharacterized arenaviruses. , 1997, Virus research.

[52]  I. Lukashevich,et al.  The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. , 1997, The Journal of general virology.

[53]  R. Zinkernagel,et al.  Virus-induced Transient Bone Marrow Aplasia: Major Role of Interferon-α/β during Acute Infection with the Noncytopathic Lymphocytic Choriomeningitis Virus , 1997, The Journal of experimental medicine.

[54]  J. Chang-Claude,et al.  Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. , 1996, The American journal of tropical medicine and hygiene.

[55]  P. Borrow,et al.  Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression , 1995, Journal of virology.

[56]  D. Brown,et al.  Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.

[57]  R. Zinkernagel,et al.  Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon , 1994, Journal of virology.

[58]  I. Lukashevich,et al.  Lassa virus activity in Guinea: Distribution of human antiviral antibody defined using enzyme‐linked immunosorbent assay with recombinant antigen , 1993, Journal of medical virology.

[59]  G. Cole,et al.  Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus , 1993, Journal of virology.

[60]  I. Lukashevich Generation of reassortants between African arenaviruses. , 1992, Virology.

[61]  J. McCormick,et al.  Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys , 1992, Journal of medical virology.

[62]  R. Zinkernagel,et al.  Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide , 1991, European journal of immunology.

[63]  S. Wilson,et al.  Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. , 1991, Virus research.

[64]  I. Lukashevich,et al.  Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences , 1990, FEBS letters.

[65]  J. Saluzzo,et al.  Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. , 1990, Vaccine.

[66]  A. Zuckerman Vaccines, cells, and nucleic acids: Workshop on vaccines prepared in continuous mammalian cell lines and by recombinant systems , 1990 .

[67]  J. Whitton,et al.  Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity , 1989, Journal of virology.

[68]  G. Lloyd,et al.  VACCINIA RECOMBINANT EXPRESSING LASSA-VIRUS INTERNAL NUCLEOCAPSID PROTEIN PROTECTS GUINEAPIGS AGAINST LASSA FEVER , 1987, The Lancet.

[69]  P. Jahrling,et al.  Experimental studies of arenaviral hemorrhagic fevers. , 1987, Current topics in microbiology and immunology.

[70]  J. McCormick,et al.  Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. , 1986, Virology.

[71]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[72]  Lukashevich Is,et al.  Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses. , 1985 .

[73]  M. Buchmeier,et al.  Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment , 1985, Journal of virology.

[74]  I. Lukashevich,et al.  Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses. , 1985, Acta virologica.

[75]  P. Jahrling,et al.  Pathogenesis of Lassa virus infection in guinea pigs , 1982, Infection and immunity.

[76]  A. Anusz [Lassa fever]. , 1981, Pielegniarka i polozna.

[77]  Sabattini Ms,et al.  Activity of lymphocytic choriomeningitis virus (LCM) in the endemic area of Argentine hemorrhagic fever (AHF). I. Serological studies in rodents captured in the City of Pergamino , 1972 .

[78]  J. Maiztegui,et al.  [Activity of lymphocytic choriomeningitis virus (LCM) in the endemic area of Argentine hemorrhagic fever (AHF). I. Serological studies in rodents captured in the City of Pergamino]. , 1972, Medicina.

[79]  J. Hotchin The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. , 1962, Cold Spring Harbor symposia on quantitative biology.